Abstract
This paper presents empirical data on motivation to join an HIV prevention trial of vaginal microbicide gels in Malawi and Zimbabwe, and participant assumption of a preventive misconception. Interviews were conducted with women participating in the trial and their male partners. Most of the female participants were able to adequately describe basic aspects of the trial design. HIV counseling and testing were primary reasons motivating women's participation, and male partners' support of the trial. 29% of women and 20% of men also provided indications of a preventive misconception, attributing gel use and trial participation to avoiding HIV infection.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Acrylic Resins / administration & dosage
-
Anti-HIV Agents / administration & dosage
-
Clinical Trials, Phase II as Topic / methods
-
Clinical Trials, Phase II as Topic / psychology*
-
Double-Blind Method
-
Female
-
HIV Infections / prevention & control*
-
HIV Infections / psychology
-
HIV Infections / transmission
-
Health Knowledge, Attitudes, Practice*
-
Humans
-
Interviews as Topic
-
Malawi
-
Male
-
Medication Adherence / psychology*
-
Motivation*
-
Naphthalenesulfonates / administration & dosage
-
Patient Participation / psychology*
-
Polymers / administration & dosage
-
Randomized Controlled Trials as Topic / methods
-
Randomized Controlled Trials as Topic / psychology*
-
Sexual Partners / psychology
-
Zimbabwe
Substances
-
Acrylic Resins
-
Anti-HIV Agents
-
BufferGel
-
Naphthalenesulfonates
-
PRO 2000
-
Polymers